Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$353M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$256M |
| 4 |
Alibaba
BABA
|
+$189M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$82M |
| 2 |
Generac Holdings
GNRC
|
+$33.7M |
| 3 |
Pool Corp
POOL
|
+$32.5M |
| 4 |
Keurig Dr Pepper
KDP
|
+$31M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Consumer Discretionary | 10.77% |
| 3 | Healthcare | 5.09% |
| 4 | Industrials | 4.03% |
| 5 | Financials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
CrowdStrike
CRWD
$195B
| $1.95M | 0.02% |
+36,736
| New | +$1.43M |
|
552
Raymond James Financial
RJF
$33.7B
| $1.93M | 0.02% |
+30,237
| New | +$1.73M |
|
553
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.57B
| $1.92M | 0.02% |
+48,000
| New | +$1.8M |
|
|
TMHC
554
DELISTED
Taylor Morrison
TMHC
| $1.92M | 0.02% |
74,986
-5,981
| -7% | -$152K |
|
555
Pulmonx
LUNG
$97.1M
| $1.92M | 0.02% |
+27,843
| New | +$1.36M |
|
556
Hycroft Mining Holding Corp
HYMC
$2.52B
| $1.92M | 0.02% |
+24,437
| New | +$1.88M |
|
557
Invesco Solar ETF
TAN
$1.28B
| $1.9M | 0.02% |
+18,500
| New | +$1.48M |
|
558
Brunswick
BC
$5.24B
| $1.89M | 0.02% |
24,840
+13,619
| +121% | +$961K |
|
559
McGrath RentCorp
MGRC
$2.85B
| $1.89M | 0.02% |
28,210
-5,257
| -16% | -$334K |
|
560
Valvoline
VVV
$4.33B
| $1.89M | 0.02% |
81,616
+60,308
| +283% | +$1.31M |
|
561
Super Micro Computer
SMCI
$24.1B
| $1.89M | 0.02% |
595,650
+45,470
| +8% | +$128K |
|
|
FOLD
562
DELISTED
Amicus Therapeutics
FOLD
| $1.88M | 0.02% |
81,190
-25,326
| -24% | -$518K |
|
|
NTUS
563
DELISTED
Natus Medical Inc
NTUS
| $1.87M | 0.02% |
93,276
+78,782
| +544% | +$1.54M |
|
564
Alcon
ALC
$35.6B
| $1.87M | 0.02% |
28,297
-34,359
| -55% | -$2.15M |
|
|
ANAT
565
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.87M | 0.02% |
19,423
+717
| +4% | +$57.8K |
|
566
American Well
AMWL
$202M
| $1.86M | 0.02% |
3,665
-781
| -18% | -$452K |
|
567
CALL
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $1.85M | 0.02% |
+35,800
| New | +$1.72M |
|
|
568
PUT
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $1.85M | 0.02% |
+35,800
| New | +$1.72M |
|
|
ZNGA
569
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.85M | 0.02% |
186,986
+23,342
| +14% | +$210K |
|
|
CIIC
570
DELISTED
CIIG Merger Corp. - Class A Common Stock
CIIC
| $1.84M | 0.02% |
+65,600
| New | +$1.19M |
|
571
CBIZ
CBZ
$2.97B
| $1.84M | 0.02% |
69,127
-4,703
| -6% | -$116K |
|
572
Qorvo
QRVO
$8.43B
| $1.83M | 0.02% |
11,030
-8,774
| -44% | -$1.29M |
|
573
Goldman Sachs
GS
$303B
| $1.83M | 0.02% |
+6,951
| New | +$1.55M |
|
574
CACI
CACI
$14.3B
| $1.83M | 0.02% |
7,327
+5,640
| +334% | +$1.3M |
|
575
PennyMac Financial
PFSI
$3.9B
| $1.83M | 0.02% |
27,838
-37,626
| -57% | -$2.24M |
|
Similar funds
Michael Gelband's Q4 2020 Portfolio in Review
As of Q4 2020, Michael Gelband held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Michael Gelband deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.
- Michael Gelband's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
- Michael Gelband added most to Amazon in Q4 2020, an estimated $353M increase.
- Michael Gelband's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
- Michael Gelband fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
- Michael Gelband's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
- Michael Gelband opened 918 new positions and closed 701 in Q4 2020.
- Michael Gelband's portfolio value rose 105% quarter-over-quarter to $10.3B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.